Results 291 to 300 of about 24,748 (316)

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

OT Oxytocin Receptor

2007
Claude Barberis, Bernard Mouillac
openaire   +1 more source

Vasopressin-Oxytocin Receptors

2007
Claude Barberis, Bernard Mouillac
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Targeting Substantia Nigra through Oxytocin Receptors.

2015
TARGETING SUBSTANTIA NIGRA THROUGH OXYTOCIN RECEPTORS. The paraventricular nucleus of the hypothalamus (PVN) contains parvocellular oxytocinergic neurons projecting to extrahypothalamic brain areas such as the hippocampus, amygdala, ventral tegmental area (VTA) and substantia nigra (SN).
Angioni Laura, Cocco Cristina, Argiolas Antonio, Ferri Gian Luca, Melis Maria Rosaria, Sanna Fabrizio   +5 more
openaire   +2 more sources

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer Msph, Lisa A Newman   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly